Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Histogen Inc. HSTO
$0.80
-$0.01 (-1.27%)
На 18:02, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
3598531.00000000
-
week52high
4.76
-
week52low
0.68
-
Revenue
3769000
-
P/E TTM
0
-
Beta
1.06669000
-
EPS
-3.24000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media solution to treat spinal disc repair; and Emricasan, an orally active pan-caspase inhibitor for the treatment of COVID-19. The company's preclinical product candidates include CTS-2090 and CTS-2096, which are selective caspase-1 inhibitors targeting inflammasome activation, as well as intervenes in a various inflammation mediated disease. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 29 мар 2022 г. |
| HC Wainwright & Co. | Buy | 30 авг 2021 г. | |
| Canaccord Genuity | Buy | Buy | 04 июн 2021 г. |
| Canaccord Genuity | Buy | 04 мар 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Mento Steven J | D | 0 | 11419 | 07 ноя 2022 г. |
| Knudson Susan A. | D | 0 | 6858 | 07 ноя 2022 г. |
| Windham-Bannister Susan Richards | A | 1000 | 1000 | 01 июн 2022 г. |
| Reyes Joyce | A | 7833 | 7833 | 01 июн 2022 г. |
| Crean David Hugh | A | 1000 | 1000 | 01 июн 2022 г. |
| Fuhrmann Rochelle | A | 1000 | 1000 | 01 июн 2022 г. |
| Jackson Jonathan | A | 1000 | 1000 | 01 июн 2022 г. |
| KISNER DANIEL L | A | 1000 | 1000 | 01 июн 2022 г. |
| Satz Brian | A | 1000 | 1000 | 01 июн 2022 г. |
| Mento Steven J | A | 151642 | 151642 | 24 февр 2022 г. |
Новостная лента
Histogen (HSTO) Upgraded to Strong Buy: Here's What You Should Know
Zacks Investment Research
10 янв 2023 г. в 13:32
Histogen (HSTO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Buying Biotech Penny Stocks? 3 Things to Look For
PennyStocks
10 ноя 2022 г. в 10:08
Are biotech penny stocks on your buy list right now The post Buying Biotech Penny Stocks? 3 Things to Look For appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Histogen to Present at the H.C. Wainwright Global Investment Conference
GlobeNewsWire
17 мая 2022 г. в 16:05
SAN DIEGO, May 17, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative therapeutics and pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases, today announced that Steven J. Mento, Ph.D., Histogen's Executive Chairman and Interim President and Chief Executive Officer, will present at the H.C. Wainwright Global Investment Conference.
Histogen to Report First Quarter 2022 Financial Results and Provide Business Update
GlobeNewsWire
28 апр 2022 г. в 16:05
SAN DIEGO, April 28, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative therapeutics and pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases, today announced that Histogen's financial results for the first quarter ended March 31, 2022 will be released after the close of market on Thursday, May 12, 2022.